Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chronic Graft-versus-host Disease (cGVHD)
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
32%
Acute Myeloid Leukemia
30%
Graft-versus-host Disease (GvHD)
26%
Myelodysplastic Syndrome
24%
Hematopoietic Cell Transplantation
18%
95% Confidence Interval
17%
Phase II Trial
15%
Decitabine
15%
Clinical Trials
12%
Bronchiolitis Obliterans Syndrome
12%
National Institutes of Health Consensus
12%
Azacitidine
12%
Matched Unrelated Donor
12%
Randomized Phase II Trial
11%
Ibrutinib
11%
Granulocyte Colony-stimulating Factor (G-CSF)
11%
High Risk
11%
Overall Survival
9%
National Institutes of Health
9%
Bone Marrow Plasma Cells
8%
Partial Response
8%
Transplantation
8%
Cardio-oncology
8%
Clinical Trials Network
8%
Unrelated Hematopoietic Stem Cell Transplantation
7%
Ruxolitinib
7%
Chronic Myeloid Leukemia
7%
Late Acute
7%
B Cell Response
7%
Natural Killer Cells
7%
Group Reports
7%
Consensus Development
7%
Treatment Response
7%
Allogeneic Hematopoietic Cell Transplant
7%
Marrow Transplant
7%
Axatilimab
7%
Belumosudil
7%
Rockstar
7%
Response Criteria
7%
Complete Response
7%
Bone Marrow
7%
Failure-free Survival
7%
Leukemia
6%
Cyclophosphamide
6%
Cell Therapy
6%
Stem Cell Mobilization
6%
Plerixafor
6%
Phase I Study
6%
Memory B Cells
6%
Immunology and Microbiology
Chronic Graft Versus Host Disease
83%
Graft-Versus-Host Disease
48%
Hematopoietic Cell
44%
Cell Transplantation
41%
Myeloid
24%
Acute Graft Versus Host Disease
23%
Overall Survival
13%
Failure Free Survival
13%
Steroid
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Infection
11%
Infectious Disease
11%
Prednisone
10%
Allogeneic Stem Cell Transplantation
9%
Cytomegalovirus
8%
Allograft
8%
Cyclophosphamide
8%
Stem Cell
8%
Blood Plasma
8%
B Cell
8%
Hematopoietic Stem Cell Transplantation
8%
Natural Killer Cell
7%
Stem Cell Transplantation
7%
Engraftment
7%
Colony Stimulating Factor 1 Receptor
6%
Plerixafor
6%
Arm
6%
Maximum Tolerated Dose
5%
Germinal Center
5%
Fascia
5%
Granulocyte Colony-Stimulating Factor
5%
Macrophage
5%
Gene Frequency
5%
CD34
5%
Stem Cell Transplant
5%
Bronchiolitis
5%
Morbidity
5%
Regulatory T Cell
5%
Immunoglobulin Producing Cell
5%
Medicine and Dentistry
Acute Myeloid Leukemia
25%
Chronic Graft Versus Host Disease
22%
Myelodysplastic Syndrome
19%
Hematopoietic Cell
17%
Clinical Trial
16%
Decitabine
11%
Plerixafor
9%
Acute Graft Versus Host Disease
9%
Cell Transplantation
8%
Diseases
8%
Cardio-Oncology
8%
Treatment Response
8%
Graft Versus Host Reaction
8%
Bronchiolitis Obliterans
7%
Azacitidine
7%
Allogeneic Stem Cell Transplantation
7%
Cancer Therapy
7%
Stem Cell Mobilization
6%
Infection
6%
Leukemia
6%
Cell Therapy
6%
Overall Survival
6%
Clinician
5%
Malignant Neoplasm
5%
Allograft
5%